The mechanisms explaining the increased IBD risk in patients with PM/DM are not completely understood, however insights from genome wide association studies point towards a common denominator including the interferon-regulatory factors such as IRF5 rs4728142 and vitamin D receptor (VDR) rs2228570 [33,34,35]. This evidence concerns the gene IRF5 and dermatomyositis.